J&J's Posdinemab Granted FDA Fast Track Designation For Alzheimer's Treatment
Johnson & Johnson (JNJ) announced that the FDA has granted Fast Track designation to its Posdinema, a monoclonal antibody ...
PortIO Completes Keiretsu Forum MST Due Diligence, Paving the Way for Fast-Track Funding
Re-Inventing Vascular Access Unlike traditional long-term vascular access devices, PortIO can remain underneath the patient's skin without the need for any maintenance with flushes. It also addresses ...